Speaker illustration

Professor Francisco Leyva

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Francisco Leyva Professor of Cardiology and Director of Medical Research at Aston University, and Consultant Cardiologist at the Queen Elizabeth Hospital, Birmingham, UK. His clinical expertise is in cardiac device therapy (CRT, pacemakers, ICDs), heart failure, cardiomyopathies and cardiovascular magnetic resonance (CMR). He is past President of the British Society of CMR (BSCMR) and has been a clinical advisor to NICE on the national guidelines for heart failure, cardiac devices and drug therapy. He has been EHRA Chair of the Health Economics Committee, EHRA Advocacy Pillar and member of the EHRA Nominating Committee. He has published extensively in the field of CRT, electrophysiology, CMR and heart failure.

Promising advances in heart failure patient management

Event: EHRA 2021

Topic: Heart Failure and Left Ventricular Dysfunction

Session type: Satellite Symposium

Thumbnail

Moderated ePosters 7: contemporary cardiac resynchronization therapy: is there room for improvement?

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session type: Moderated Posters

Thumbnail

Best graded abstracts session

Event: EHRA 2018

Topic: Miscellaneous

Session type: Abstract Sessions

Thumbnail

Novel approaches to CRT optimisation

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session type: New ESC Guidelines

Thumbnail

Beyond CRT - Device therapy in advanced heart failure

Event: EHRA 2018

Topic: Cardiac Resynchronization Therapy

Session type: How To ...

Thumbnail

Latest developments in pacemaker therapy

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Cardiac Pacing

Session type: Satellite Symposium

Thumbnail

What is new in cardiac rhythm management?

Event: ESC Congress 2016

Topic: Antibradycardia pacing

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb